NDUFB5P1

Across TCGA pan-cancer cohorts, NDUFB5P1 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated NDUFB5P1 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher NDUFB5P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NDUFB5P1 expression acts as an unfavorable survival marker, although some lineages such as ESCA and PCPG show a favorable association.

CESC, LUAD, and SKCM are the cancer types where NDUFB5P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	All	0.481	0.802	.002	36	view →
LUAD	OS	Tertile	IV	0.114	0.560	.038	27	view →
SKCM	DFS	Tertile	III,IV	0.309	0.525	.012	21	view →
STAD	OS	Tertile	IV	0.165	0.578	.016	18	view →
ESCA	OS	Tertile	III,IV	0.673	0.362	.028	15	view →
ACC	OS	Tertile	All	0.297	0.771	.010	12	view →
KIRP	DFS	Tertile	All	0.748	0.876	.007	9	view →
SARC	OS	Tertile	All	0.702	0.843	.046	3	view →
PCPG	DFS	Median	All	0.944	0.836	.039	1	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

NDUFB5P1–CESC (OS)

Open the CESC breakdown →